Exabis Library
Welcome to the e-CCO Library!
P036 A novel p53-mediated mouse model of inflammatory bowel disease-associated colorectal cancer
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P036: Analysis of intestinal tissue from newly diagnosed patients with inflammatory bowel disease reveals distinct proteomic profiles
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P036: Colon targeted delivery of tofacitinib inhibits oxazolone-induced colitis in mice, despite low systemic exposure
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P036: Expression of CD69 on peripheral lymphocytes predicts treatment response in Acute Severe ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P036: Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P036: Human peripheral blood monocytes and intestinal macrophage populations activate transforming growth factor beta via expression of the integrin alpha v beta 8
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P036: Identification and functional analysis of stromal subsets in experimental IBD mouse models
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P036: MicroRNA composition of colon crypt-top and crypt-bottom epithelial cells in Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P037 Antagonism of chemokine receptor CCR9 synergises with anti-TNFα immunotherapy to reduce inflammation in the MDR1a−/− mouse model of colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P037: Bacterial handling defect in macrophages of patients with defects in glucose-6-phosphate metabolism and Crohn’s disease like intestinal inflammation
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P037: Enhancing the efficacy of cannabidiol using protein nanoparticles to treat inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P037: MDR1-deficiency unmasks mitochondrial dysfunction as a pathogenic mechanism in IBD
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P037: MicroRNA-31 and microRNA-200 family reflect disease activity in Crohn’s disease: results from the BIOMIR study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P037: Nonclinical pharmacokinetics and absorption, distribution, metabolism, and excretion properties of MORF-057 support its clinical development as an oral selective α4β7 integrin inhibitor
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P037: Remodelling events preceding clinical onset of intestinal inflammation reveal the predictive power of the extracellular matrix
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P037: USP16-mediated deubiquitination of calcineurin A controls peripheral T cells maintenance and attenuates intestinal inflammation
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P038 A single-cell transcriptomics approach reveals high-resolution cellular signatures in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P038: Expression analysis in colitis-associated carcinoma: a role for osteopontin?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P038: Microbial regulation of T-cell fate towards regulatory profiles during T-cell transfer induced colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P038: Notch pathway in fibrosis: a new anti-fibrotic therapy in Crohn's disease?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM